Trademark Search in Canada

KLIRMYLO

View On IC.GC.CA

REGISTERED

on 4 Oct 2024

Last Applicant/ Owned by

ALEXION PHARMACEUTICALS INC.

121 Seaport BoulevardBoston MA 02210

Serial Number

2186649 filed on 7^th Apr 2022

Registration Number

TMA1261246 registered on 4^th Oct 2024

Registration expiry Date

7^th Apr 2032

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa

ONTARIO

K1P5Y6

KLIRMYLO

Trademark usage description

pharmaceutical preparations for the treatment of autoimmune diseases and disorders, protein aggregation-related diseases and disorders, namely, diseas Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of autoimmune diseases and disorders, protein aggregation-related diseases and disorders, namely, diseases caused by protein deposition, abnormal proteins, production and aggregation-related diseases and disorders, namely, amyloidosis, and neurodegenerative diseases and disorders.

Classification kind code

Mark Details

Serial Number

2186649

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 8^th Nov 2023	Agent Changed
Submitted for opposition 22 on 21^st Aug 2023	Search Recorded
Submitted for opposition 20 on 21^st Aug 2023	Examiner's First Report
Submitted for opposition 223 on 21^st Aug 2023	Total Provisional Refusal
Submitted for opposition 256 on 20^th Mar 2023	Notification of Possible Opposition Sent
Submitted for opposition 257 on 19^th May 2022	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 18^th May 2022	Formalized
Submitted for opposition 1 on 18^th May 2022	Created
Submitted for opposition 228 on 7^th Apr 2022	International Registration
Submitted for opposition 30 on 7^th Apr 2022	Filed